ライフサイエンスコーパス: -producing cell

1 We studied collagen-I(alpha)1-producing cells in normal and diseased lungs using Coll-

2 Immunocytostaining showed that ET-1-producing cells emerged only in PBMCs stimulated with an

3 further implicate GC TFH as the major HIV-1-producing cells in chronic asymptomatic HIV-1 infection.

4 Blocking this pathway in HIV-1-producing cells resulted in less infectious progeny viri

5 ent arms led to induction of dual IL-4/IL-10-producing cells during the pollen season.

6 tive IL-10 and suggest interference by IL-10-producing cells in the detection of drug-specific T cell

7 nvestigated the origin and function of IL-10-producing cells in the tumor microenvironment using tran

8 stimulation and increased induction of IL-10-producing cells of several types, including Tr1 cells, f

9 1 cells in T1D patients, while Th2 and IL-10-producing cells were prevalent in healthy adults.

10 acrophages (Mvarphis) constituted most IL-10-producing cells.

11 d [ie, CD163(+)] macrophages, interleukin 10-producing cells, and transforming growth factor beta-pro

12 -4-induced conversion of IFN-gamma- to IL-13-producing cells without affecting expression of the line

13 mpassing a spectrum from IFN-gamma- to IL-13-producing cells, is pivotal in the development of allerg

14 ating into interleukin-18 (IL-18)- and IL-15-producing cells in an inflammasome and type I interferon

15 emical evidence of apoptotic cells and IL-15-producing cells proximal to B-CLL pseudofollicles in pat

16 into proinflammatory interleukin-17 (IL-17)-producing cells by inflammatory mediators and thereby lo

17 reduced the number of interleukin-17 (IL-17)-producing cells in the intestine and production of granu

18 s are a population of interleukin 17 (IL-17)-producing cells that acquire effector function in the th

19 vivo severely impeded the expansion of IL-17-producing cells after viral infection.

20 They decreased IL-17-producing cells and increased the level of circulating I

21 IL-17-producing cells are important mediators of graft-versus-

22 Most IFN-gamma- and IL-17-producing cells expressed high levels of CD226, but prod

23 re sources of IFN-gamma and IL-17, and IL-17-producing cells expressed RORgammat.

24 I3Kdelta, blocked chemotaxis of CCR6(+)IL-17-producing cells from IMQ-treated mice or healthy human d

25 nd reduced frequency of IFN-gamma- and IL-17-producing cells in draining lymph nodes.

26 Loss of IL-17-producing cells in the gut during HIV infection is linke

27 A majority of the IL-17-producing cells in the liver were gammadelta T cells.

28 -17 and underlying mechanisms by which IL-17-producing cells promote human colorectal cancer (CRC) re

29 IFN-gamma and IL-17-producing cells specific for the hemagglutinin and nucle

30 The increase in IL-17-producing cells was not restored to normal levels in wil

31 rrelates with increased frequencies of IL-17-producing cells within these T cell populations.

32 erols, showed significant reduction of IL-17-producing cells, including CD4(+) and gammadelta(+) T ce

33 Intestinal IL-17-producing cells, including Th17, gamma/delta T, and inna

34 ffects on inhibition of IFN-gamma- and IL-17-producing cells.

35 Percentages of interleukin 17-producing cells were significantly higher in spleen and

36 mma (IFN-gamma) and interleukin 17A (IL-17A)-producing cells are described to be related to the prote

37 In contrast, IL-17A-producing cells (CD3(+)CD4(+), CD3(+)CD4(-), and CD3(-)C

38 ence of IkappaBNS, the frequencies of IL-17A-producing cells are drastically reduced.

39 Lung IL-17A-producing cells were identified by fluorescence-activate

40 A significantly lower fraction of IL-2-producing cells and a decrease in functional avidity and

41 could provide help to neighboring, non-IL-2-producing cells to differentiate into IFN-gamma-producin

42 s induced a high frequency of CD127(+), IL-2-producing cells with decreased expression of Tbet compar

43 ouse models that the relative number of IL-2-producing cells within Ag-specific CD8(+) T cell populat

44 and frequency of blood and intestinal IL-21-producing cells in nonhuman primates that are hosts of p

45 A variety of IL-22-producing cell types is known, but identification on the

46 that would allow the identification of IL-22-producing cells and their fate mapping in vivo.

47 Depleting IL-22-producing cells during the healing phase impaired epithe

48 secretion assays detecting IL-17A- and IL-22-producing cells in a single purification step.

49 re, an increase in proportion of these IL-23-producing cells was detected only in tumor models where

50 ustained reduction in allergen-specific IL-4-producing cell counts (P < .01).

51 4 and constitute up to 70% of the total IL-4-producing cells during the initial stages of infection.

52 e were no differences in frequencies of IL-4-producing cells within any of the memory compartments co

53 IgG4 (sIgG4) levels and an increase in IL-4-producing cells, followed by downregulation of the TH2 r

54 or the conditional deletion of distinct IL-6-producing cell types to show that dendritic cells (DCs)

55 blast IL-6 regulation, but not in other IL-6-producing cell types.

56 To what extent IL-9-producing cells are induced or regulated by sensitizatio

57 pecific cytokine IL-5 suggests that the IL-9-producing cells belong to the recently described TH9 sub

58 There are fewer IgG1 Ab-producing cells in the bone marrow of cKOs.

59 nic stimulation and their transition into Ab-producing cells.

60 h T cells, and their differentiation into Ab-producing cells.

61 but rather by the adipokinetic hormone (AKH)-producing cells of the corpora cardiaca, and we demonstr

62 Furthermore, activation of AKH-producing cells alone was sufficient to enhance longevit

63 CYP11B2-expressing cells, called aldosterone-producing cell clusters, were analyzed.

64 CYP11B2 expression and increased aldosterone-producing cell cluster expression.

65 The integrated ratio of aldosterone-producing cell cluster to CYP11B2-expressing area was mo

66 Recently, aldosterone-producing cell clusters (APCCs) with high expression of

67 31, P<0.0001), whereas the total aldosterone-producing cell cluster area was positively correlated wi

68 and tumor necrosis factor alpha (TNF-alpha)-producing cells displaying the highest and lowest preval

69 quencies of tumor necrosis alpha (TNF-alpha)-producing cells, whereas atypical MBCs expressed high le

70 alance between pDC maturation into IFN-alpha-producing cells or development of an APC phenotype diffe

71 with an APC phenotype rather than IFN-alpha-producing cells.

72 is not due to immediate killing of TNF-alpha-producing cells but rather results from a rapid downregu

73 of IL-4-, IL-17-, IFN-gamma-, and TNF-alpha-producing cells compared with T cells lacking CD20.

74 The spectrum of TNF-alpha-producing cells in patients with psoriasis, as well as t

75 PV23]), IgG anti-caps-PS serotype 4 antibody-producing cells resided mainly in the CD19(+) CD5(-) B c

76 by which removal of antibodies and antibody-producing cells improve neurological function, and offer

77 are primarily thought of as natural antibody-producing cells.

78 in the immune system, in particular antibody-producing cells and B lymphocytes.

79 ces, and the loss of HIV-1-specific antibody-producing cells during development.

80 B cells, and more antigen-specific antibody-producing cells in co-infected C3H mice compared to B6 m

81 serious pathologies of B cells, the antibody-producing cells of the immune system.

82 e late enhancer controls br in the appendage-producing cells, but the function of the early enhancer

83 y analysis revealed that the nucleoid in ArT-producing cells is concentrated and appears hollow.

84 lls also more readily generated autoantibody-producing cells than HSPCs with lower levels of ARID3a i

85 cting not only as precursors of autoantibody-producing cells but also as antigen-presenting, cytokine

86 g cells, and transforming growth factor beta-producing cells), along with reduced lymphoid tissue fib

87 FP reporter mice, we identify these IFN-beta-producing cells in the spleen as a CCR9(+)CD9(-) pDC sub

88 y require the development of single biologic-producing cell lines followed by their cultivation at ve

89 subsides, indicating that the peri-islet BM-producing cells are not lost due to the inflammation, wh

90 chymal cells that function as the major bone-producing cells of the body.

91 ociated lymphoid tissue (BALT), where VEGF-C-producing cells were scattered in T-cell zones.

92 c cells in the kidney were detected as CCL18-producing cells.

93 ggesting that M2 macrophages are major CCL18-producing cells in NPs.

94 In conclusion, loss of Twist1 in collagen-producing cells led to increased bleomycin-induced pulmo

95 ollagen synthesis by HSCs, the main collagen-producing cells in liver fibrosis.

96 and have a higher concentration of collagen-producing cells.

97 ables have unique interactions with collagen-producing cells.

98 llow the purification of any single cytokine-producing cell subset, and the combination of several di

99 nes because both cytokine input and cytokine-producing cells play key roles.

100 and infer that the differentiated, cytokine-producing cells cycle faster than early activated precur

101 ntigen exposure, with more frequent cytokine-producing cells in the CD103(-) population.

102 ry T (Treg) cells into inflammatory cytokine-producing cells is thought to be an important step in th

103 Phenotypic characterization of cytokine-producing cells was performed by FACS.

104 f CD8 T cells and the generation of cytokine-producing cells were significantly reduced by the lack o

105 differentiation into polyfunctional cytokine-producing cells.

106 Tomato) dual-reporter mice to study cytokine-producing cells during allergic inflammation.

107 lated with increased numbers of Th2-cytokine-producing cells (Rs=0.56, P=0.002 and Rs=0.54, P=0.004 f

108 genes of SoxN that are expressed in denticle-producing cells and that are regulated independently of

109 neural crest cells give rise to the dentine-producing cells (odontoblasts) of teeth.

110 17 cells give rise to IL-17/IFN-gamma double-producing cells and Th1-like IFNgamma(+) ex-Th17 lymphoc

111 ion of Th17 cells to IL-17A/IFN-gamma double-producing cells as well as Th1-like IFN-gamma(+) ex-Th17

112 on the generation of IL-17/IFN-gamma double-producing cells, but leads to a marked absence of Th1-li

113 (IL-17A)- and interferon (IFN)-gamma-double-producing cells that are implicated in development of au

114 ighly expressed in stromal cells next to Dpp-producing cells and functions to remove excess Dpp outsi

115 he grafts promotes destruction of endostatin-producing cells, resulting in corneal neovascularization

116 the role of the PHD/HIF-2 axis in renal EPO-producing cell (REPC) plasticity is unclear.

117 thod that marked current and/or previous Epo-producing cells and revealed that the majority of myofib

118 how that the cellular phenotype of renal Epo-producing cells (REPs) alternates between a physiologic

119 In human erythropoietin-producing cells, hCMV inhibited hypoxia-induced expressi

120 -like cells resembling native erythropoietin-producing cells located in the tubulointerstitium.

121 diaphragm, and appearance of erythropoietin-producing cells.

122 Renal erythropoietin-producing cells (REPCs) remain in the kidneys of patient

123 gical stimuli of angiogenic phenotypes in EV-producing cells can enhance the potency of EVs for vascu

124 in the same microenvironment as the exosomal-producing cells in vivo.

125 ence for a significant expansion of IL-17A/F-producing cells in mouse liver within 24 h of adenovirus

126 st a mechanism for the coordination of force-producing cell behaviors across the embryo.

127 gesting that M2 macrophages are major FXIIIA-producing cells in NP.

128 g ASFV-specific gamma interferon (IFN-gamma)-producing cells.

129 An expansion of IFN-gamma-producing cells and intracytoplasmic IFN-gamma levels wa

130 ing review, we discuss the role of IFN-gamma-producing cells and the signals that regulate IFN-gamma

131 n; however, the mechanism by which IFN-gamma-producing cells are recruited to the sites of inflammati

132 8 T cell development to IL-17- and IFN-gamma-producing cells during sensitization.

133 initial step in the chemotaxis of IFN-gamma-producing cells in chemically induced skin inflammation.

134 orrelate with increased numbers of IFN-gamma-producing cells in the repertoire.

135 rare population of nonconventional IFN-gamma-producing cells of hematopoietic origin that were charac

136 ficantly lower frequency of CLA(+) IFN-gamma-producing cells was observed in patients with AD, with n

137 days 4 and 7 postimmunization, and IFN-gamma-producing cells were detected in all pigs analyzed follo

138 Shortly after challenge, IFN-gamma-producing cells were highly enriched for Ly6C(+)T-bet(+)

139 matory chemokines, infiltration of IFN-gamma-producing cells, and additional production of inflammato

140 ated, differentiated into T-bet(+) IFN-gamma-producing cells, and infiltrated the pancreas.

141 lood-derived Tregs into IL-17- and IFN-gamma-producing cells, even in the presence of the IL-17-drivi

142 otential protective role for these IFN-gamma-producing cells.

143 ressing (DT) mice that specifically lack GIP-producing cells were backcrossed five to eight times ont

144 rs Hedgehog (Hh) ligand at the surface of Hh-producing cells within the ovary, limiting FSC prolifera

145 s to be learned about these varied histamine-producing cell populations.

146 Depleting histamine-producing cells enforces cell cycle entry, induces loss

147 d at investigating the function of histamine-producing cells.

148 coordinated development of distinct hormone-producing cell types and an invading vascular network.

149 ior pituitary harbours five distinct hormone-producing cell types, and their cellular differentiation

150 hormone and proliferation of growth hormone-producing cells.

151 Intestinal hormone-producing cells represent the largest endocrine system i

152 t pancreata, but fail to mature into hormone-producing cells.

153 s also provide evidence that many of hormone-producing cells within the adult islet represent heterog

154 owth, but not the differentiation of hormone-producing cells.

155 ors and is also found in a subset of hormone-producing cells.

156 docrine progenitor cells and progeny hormone-producing cells, indicating that Area II activity is fun

157 reduction in numbers of most of the hormone-producing cells before birth, with the exception of cort

158 DCs) are the major type I interferon (IFN-I)-producing cells, and IFN-I actually contributes to patho

159 re the most potent type I interferon (IFN-I)-producing cells.

160 tic cells (pDCs) are the most powerful IFN-I-producing cells and play important roles during viral in

161 , they are not considered professional IFN-I-producing cells.

162 e considered to be "professional" type I IFN-producing cells and produce 10- to 100-fold more IFN-alp

163 We define "professional type I IFN-producing cells" as a distinct subset of pDCs specialize

164 een regarded as the "professional type I IFN-producing cells" of the immune system following viral re

165 helial cell amplification loop involving IFN-producing cells and virus-infected pulmonary epithelial

166 ersion of fibroblasts into highly potent IFN-producing cells and rendered these cells resistant to pa

167 In parallel, human pDCs are potent IFN-producing cells upon MERS-CoV infection.

168 stand the selective pressures shaping the Ig-producing cell repertoire in the parotid glands of prima

169 ssues, IgG was the dominant isotype among Ig-producing cells, and 60% of IgG-positive cells produced

170 The Ig-producing cells and the proportion of cells producing Ga

171 fewer B cells, and they are enriched for IgA-producing cells.

172 In vitro, we used an IgA1-producing cell line to confirm that miR-148b modulates I

173 oreover, the proportion of Gal-deficient IgG-producing cells directly correlated with clinical parame

174 d differentiation into non-NTHi-specific IgM-producing cells.

175 of CD4(+) T cells into IFN-gamma- and IL17A-producing cells, and that both T-cell phenotypes are lin

176 plasic, with an increased number of incretin-producing cells compared with the corresponding jejunal

177 at modulation of the development of incretin-producing cells in the intestine has potential as a ther

178 ations of activity in LK neurons and insulin-producing cells (IPCs) in adult flies and monitored food

179 endothelial cells, hepatocytes, and insulin-producing cells differentiated from hPSCs, respectively.

180 HNF4 is required in the fat body and insulin-producing cells to maintain glucose homeostasis by suppo

181 ced pluripotent stem cells to create insulin-producing cells from individuals with Wolfram syndrome.

182 These rats developed insulin-producing cells within the upper intestine in numbers su

183 We found that Drosophila insulin-producing cells (IPCs), which are located in the pars in

184 pancreas can give rise to endocrine insulin-producing cells upon ectopic expression of key transcrip

185 increasing the number of endogenous insulin-producing cells in diabetics.

186 s is an evidence for extrapancreatic insulin-producing cells.

187 sphinganine is a cytotoxic lipid for insulin-producing cells, suggesting that the increased levels of

188 n varies, making it hard to sort for insulin-producing cells.

189 stem cells are capable of generating insulin-producing cells in vitro when provided with the appropri

190 ponse to dietary conditions, but how insulin-producing cells (IPCs) coordinate their responses to dis

191 However, insulin-producing cells previously generated from human pluripot

192 unlimited source of functional human insulin-producing cells and 2) prevention of rejection without t

193 erized and unlimited source of human insulin-producing cells.

194 g protein 6 (ZBED6), is expressed in insulin-producing cells and, if so, to what extent it affects be

195 rmined that GX sPLA2 is expressed in insulin-producing cells of mouse pancreatic islets and investiga

196 overload, underlie glucotoxicity in insulin-producing cells.

197 rowth by direct differentiation into insulin-producing cells and by mitigating the cytotoxicity of in

198 Surprisingly, their development into insulin-producing cells was significantly delayed in male compar

199 that efficiently converts hESCs into insulin-producing cells.

200 es (T1D) involves replacing the lost insulin-producing cells with new ones, preferably cells from a w

201 that the pancreas reconstitutes new insulin-producing cells in the absence of autoimmunity.

202 etes requires an unlimited source of insulin-producing cells and the ability to block the pathologica

203 dramatically increased the number of insulin-producing cells in vitro, demonstrating the need for dyn

204 insulin genes nor the development of insulin-producing cells in vitro.

205 ls and histopathological evidence of insulin-producing cells or molecular markers of endocrine tissue

206 tion or gut organoids as a source of insulin-producing cells to treat human diabetes.

207 concerns include immunoisolation of insulin-producing cells with porous biomaterials that function a

208 ls to generate a renewable source of insulin-producing cells.

209 ed in plasma and almost no remaining insulin-producing cells were present in the pancreas.

210 1D, assuming that glucose-responsive insulin-producing cells are available for transplantation.

211 ferentiated into glucose-responsive, insulin-producing cells by ablation of transcription factor Foxo

212 ansplantation of glucose-responsive, insulin-producing cells offers the potential for restoring glyce

213 itional Cre-mediated manner, so that insulin-producing cells express GFP under control of the insulin

214 ess in the fly by acting through the insulin-producing cells (IPCs) in the fly brain.

215 at select expression of dfmr1 in the insulin-producing cells (IPCs) of the brain was sufficient to re

216 o 7 median neurosecretory cells: the insulin-producing cells (IPCs).

217 e mutation or diabetes status, these insulin-producing cells are immature, a common downfall off most

218 Generation of transplantable insulin-producing cells from human embryonic stem cells or induc

219 ell as the viability of transplanted insulin-producing cells.

220 trieved after 174 d contained viable insulin-producing cells.

221 tic cells (pDCs) are major type-I interferon-producing cells that play important roles in antiviral i

222 dendritic cells (pDC) are type I interferon-producing cells with critical functions in a number of h

223 mine whether GPR30 colocalizes with isotocin-producing cells in the preoptic area, a critical node in

224 The implantation of such levodopa-producing cells can concurrently decrease the elevated m

225 as demonstrated by the numbers of Hh-ligand-producing cells (P < 0.0001) and Hh-responsive (glioma-a

226 vity (evidenced by accumulation of HH-ligand-producing cells and HH-responsive target cells) strongly

227 Sonic Hh (Shh) ligand-producing cells and Shh-responsive cells were quantified

228 expressed in surfactin-producing and matrix-producing cells, respectively.

229 nteraction of surfactin-producing and matrix-producing cells.

230 on of T cells and bone marrow-derived matrix-producing cells.

231 enhances nutrient uptake, and enables matrix-producing cells to outcompete non-matrix-producing cheat

232 ogies, as a mediator of extracellular matrix-producing cells.

233 their substrate, thereby facilitating matrix-producing cells to form bundles.

234 nd tapA; these genes are expressed in matrix-producing cells.

235 McC-producing cells also induce persistence in sensitive cel

236 McC-producing cells have increased persistence levels due to

237 These MMP12-producing cells showed reduced surface levels of the coi

238 MUC5AC-containing mucus gel domains to mucus-producing cells in the epithelium.

239 yticus strain UCN34, adhered better to mucus-producing cells such as HT-29-MTX than to the parental H

240 of interferon gamma (IFNG)-producing and non-producing cells purified by flow cytometry.

241 Neutrophils are a major source of OSM-producing cells in patients with CRS and severe asthma.

242 Melanocytes are pigment-producing cells of the epidermis, precursors for melanom

243 he melanocytic lineage, highlighting pigment-producing cells as the melanoma cell of origin, and indi

244 sitive cells, continuous loss of the pigment-producing cells from the epidermis, and development of v

245 rest-derived cells that generate the pigment-producing cells of our body.

246 ineage analysis of ommochrome- and porphyrin-producing cells in the brown, freshwater planarian Schmi

247 eceptor 2 (VEGFR2) expressed in PD prolactin-producing cells known to impair gonadotrophin secretion.

248 alized jugular vein delivery of prostacyclin-producing cells may provide sustained therapeutic effect

249 immunohistochemistry staining, IL-21 protein-producing cells were present in all gastrointestinal tra

250 regulated VEGF expression in cultured renin-producing cells.

251 However, renin-producing cells of Vhl (-/-(REN)) mice expressed the ery

252 ney and can differentiate into JG-like renin-producing cells under conditions that promote JG cell re

253 se mice had an attenuated expansion of renin-producing cells in response to a low-salt diet combined

254 e a dramatic increase in the number of renin-producing cells in the kidney, termed JG cell recruitmen

255 ciate with hyperplasia or expansion of renin-producing cells, but it is unknown whether hypoxia-trigg

256 elopment and physiologic adaptation of renin-producing cells.

257 sma virus was associated with each HIV-1 RNA-producing cell in women as compared to men, suggesting t

258 Women had marginally fewer HIV-1 RNA-producing cells (mean, 0.21 cells/mm(2)) than men (mean,

259 ter adjusting for the frequency of HIV-1 RNA-producing cells and potential confounders, the viral loa

260 The frequencies of HIV-1 RNA-producing cells in the lymph node were determined by in

261 edict viral load or frequencies of HIV-1 RNA-producing cells, indicating that physiologic levels of C

262 human gut endocrine progenitor and serotonin-producing cells.

263 duced by the endocrine L cells and serotonin-producing cells.

264 s the additional digit to arise from the Shh-producing cells of the polarizing region - an ability lo

265 sicles along cytonemes emanating from signal-producing cells to form a gradient in Drosophila epithel

266 are more likely to differentiate into signal-producing cells.

267 ptomatic infection prior to simian AIDS, SIV-producing cells were more concentrated in follicular (F)

268 ymphoid B cell follicles, where HIV- and SIV-producing cells are most highly concentrated, indicating

269 ot able to clear all follicular HIV- and SIV-producing cells.

270 of CD8 depletion on levels of follicular SIV-producing cells in chronically SIV-infected rhesus macaq

271 ntly, after CD8 depletion, the number of SIV-producing cells increased in B cell follicles and extraf

272 on, there was no compartmentalization of SIV-producing cells.

273 tent allowed us to rapidly determine the STX-producing cell concentrations of two Alexandrium species

274 We propose that surfactin-producing cells reduce the friction between cells and th

275 nterferon (IFN)-gamma (Th1) and IL-17 (Th17)-producing cells.

276 Induction of both Th17-producing cells and Tregs is caused preferentially by Tr

277 sis and later differentiation of hard tissue-producing cells.

278 receptor, is predominantly expressed by TNF-producing cells, suggesting a novel cellular hierarchy f

279 aste cells, which are different from the TNF-producing cells in mouse circumvallate and foliate taste

280 alysis of diseased kidneys and purified UMOD-producing cells revealed early activation of the PKR-lik

281 VEGF164- and VEGF120-producing cells (fs164 and fs120 respectively) were less

282 The vesicle-producing cells induce MV formation in neighboring cells

283 stinct times and locations: (i) in the virus-producing cell prior to viral release, yielding a DNA-co

284 mino acid transporter-1 (mCAT1) in the virus-producing cell.

285 Whether GC TFH are the major HIV-1 virus-producing cells in vivo has not been established.

286 ells, as well as replication-competent-virus-producing cells, were measured to quantified viral repli

287 of HIV-1 DNA and replication-competent-virus-producing cells.

288 IV-1 precursor Gag (PrGag) proteins in virus-producing cells using a biotin ligase-tagging approach.

289 reased HIV-1 Gag protein expression in virus-producing cells, while silencing the m(6)A erasers incre

290 sor of the Gag (Pr55(Gag)) of HIV-1 in virus-producing cells.

291 The average number of virus-producing cells in peripheral blood is small during chro

292 enhancing immune-mediated clearance of virus-producing cells is of high priority.

293 Finally, treatment of virus-producing cells with Chk inhibitor protects them from vi

294 ion through the exocytic organelles of virus-producing cells, and second after virus binding to targe

295 cell-to-cell transmission because the virus-producing cells cannot be easily distinguished from infe

296 ages were a significant portion of the virus-producing cells found in LNs, intestinal tissues, and lu

297 from lymphoid B cell follicles, where virus-producing cells are most highly concentrated, suggesting

298 ene required for Wnt ligand secretion by Wnt-producing cells, specifically in the hair follicle epith

299 hat basal subclones recruit heterologous Wnt-producing cells to restore tumour growth.

300 opment, but the identity and role of the Wnt-producing cells are still unclear.